DNAstack secures new financing from FACIT

FACIT’s Compass Rose Oncology Fund has invested in DNAstack. FACIT’s Prospects Oncology Fund initially invested in 2017.

Toronto based DNAstack is developing advanced data standards and technologies that make it easier for scientists to find, access, analyze and share complex and large volumes of multi-omics data in the cloud.

Full story: FACIT’s Compass Rose Oncology Fund invests in DNAstack

CPE Media News

Canada's only complete private capital and public financing news and intelligence provider.